SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882796-05-000032
Filing Date
2005-07-13
Accepted
2005-07-13 17:17:42
Documents
1
Period of Report
2005-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 16142
  Complete submission text file 0000882796-05-000032.txt   17984
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOCRYST PHARMACEUTICALS, INC 2190 PKWY LAKE DRIVE BIRMINGHAM AL 35244
Business Address 2054444600
BENNETT J CLAUDE (Reporting) CIK: 0001198766 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 05952936